Oncology/Hematology CE Courses – Update

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.


Featured CE Courses

New Therapeutic Options in AML: An Update for Community Clinicians

Updates in AML for Community Clinicians | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
Have you heard about the latest clinical advances in AML therapy? Join Drs Strickland and Wang as they discuss recent science that provides guidance for the care team on the use of newly approved and novel strategies for AML management.
Improving Care for Patients With HER-2 Positive Breast Cancer: A Worldwide Collaboration

Improving Care for Patients With HER-2 Positive Breast Cancer: A Worldwide Collaboration | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
Despite the sobering statistics, there has been an explosion of innovation that is providing clinicians with powerful new tools and targeted therapies that give hope to patients with HER2-positive advanced breast cancer. In this video presentation, six experts representing Australia, Asia, Africa, Europe, and the Americas, collaborate on caring for a patient who presents with HER2-positive breast cancer.
AL Amyloidosis: Identifying Patients, Implementing Care

AL Amyloidosis: Identifying Patients, Implementing Care | myCME

AMA PRA Category 1 Credit(s)TM, ABIM MOC Points, CNE Contact Hour(s)
This activity features a roundtable discussion with a multidisciplinary panel of experts on the latest information on evidence-based diagnosis and treatment guidelines for patients with AL amyloidosis.
Expert Perspectives on Rare Disease: Promoting Recognition, Diagnosis and Treatment of Cold Agglutinin Disease

Promoting Recognition, Diagnosis and Treatment of CAD

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
In this activity, Catherine M. Broome, MD, and Alexander Röth, MD, provide an understanding of the pathogenesis of Cold Agglutinin Disease (CAD) caused by cold-reacting IgM autoantibodies and reveal common clinical features.
The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer: Guidance for Today and the Path Forward

The Role of Antibody Drug Conjugates in Advanced Non-Small Cell Lung Cancer | myCME

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists, CNE Contact Hour(s)
In this CME Outfitters Live and OnDemand, integrations of animated 3-D models will provide visual representation of the mechanisms and characteristics of antibody drug conjugates (ADCs) in NSCLC to complement expert faculty insights and evidence supporting testing strategies to identify predictive biomarkers, emerging treatment options for advanced or metastatic NSCLC, and best practices for managing patients with lung cancer in the face of COVID-19 and beyond.
Disparities and Improving the Care of Advanced HCC in the Hispanic Community

Disparities and Improving the Care of Advanced HCC in the Hispanic Community | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
Significant race and ethnicity-specific disparities in HCC care account in many respects for the increased incidence—approximately 36%—of HCC among Hispanics, who are more likely to present late and less likely to receive any HCC-directed treatment. However, improved screening and surveillance guidelines and greater understanding of the pathophysiology and molecular pathways in HCC has led to the emergence of targeted treatment.

Click for Oncology More Courses

Next post in CE Courses